奇宁注射液治疗晚期原发性肝癌的研究

Study of Qining injection on primary liver cancer in later period

目的 观察奇宁注射液治疗晚期原发性肝癌的近期疗效。方法 选择 5 2例晚期肝癌患者随机分为 2组 ,观察组采用以奇宁注射液为主的综合治疗 ,对照组给予保肝及对症治疗 ,观察两组治疗前后临床症状、生活质量及血清AFP的变化。结果 观察组患者临床症状明显改善 ,生活质量明显提高 ,血清AFP明显降低 (P <0 .0 5 )。对照组治疗前后血清AFP变化无统计学意义 (P >0 .0 5 )。结论 奇宁注射液是治疗晚期肝癌安全有效的药物。

Objective It is to observe the recent clinical effect of Qining injection on primary liver cancer in later period.Methods 52 patients with liver cancer in later period were randomly divided into two groups. Observation group was mainly treated with Qining injection, control group was treated with protecting the liver and heteropathy. Then the clinical symptoms, life quality and the changes of serum α-fetoprotein (AFP) in the two groups were observed after treatment.Results In observation group after treatment, the clinical symptoms improved evidently, the life quality was improved and the serum AFP reduced ( P <0.05). But the change of the serum AFP in control group had no obvious difference before and after treatment ( P >0.05).Conclusion Qining injection is a secure and effective medicament for patients with liver cancer in later period.